Industry News

M and A Navigator: Deal pipeline –5 August
Veeva Systems Inc., a leading provider of industry cloud solutions for life sciences, will announce financial results for its fiscal second quarter which ended July 31, 2016 after market close on August 30, 2016. Veeva will host a conference call and webcast that day at 1:30 p.m. PT to discuss its financial results. A webcast replay will be available on Veeva’ s investor relations website following the call."/>
Veeva to Release Fiscal 2017 Second Quarter Results on August 30, 2016
Cytori Therapeutics, Inc., a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions, announced today that the Compensation Committee of the Company's Board of Directors granted to Mark Marino, M.D., Senior Vice President of Clinical Affairs, a non-qualified stock option to purchase an aggregate of 33,333 shares of the Company's common stock with a per share exercise price of $2.18, the closing..."/>
Cytori Therapeutics Announced Inducement Grant for New Employee
Celgene Corporation as its October 2016 "Stock to Study" and Amgen Inc., as its October 2016 "Undervalued Stock" for investors' informational and educational use. "The committee selected Celgene for its high growth potential of cancer-treatment drugs in coming years coupled with a reasonable valuation," said Adam Ritt, editor of..."/>
BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
DATATRAK International, Inc., a leader in cloud-based, unified dClinical ® technologies and related services for the clinical trials industry, today announced its operating results for the second quarter of 2016.. Revenue increase of 2% over same period in the prior year Gross margin of 84% for Q2 2016 compared to 77% in Q2 2015 Reduction of 48% in SG&A spending Q2 2016 vs. Q2 2015 Net income from operations of $330,000 compared to a net loss from..."/>
Second Quarter 2016 Results Reported for DATATRAK International, Inc.
American Shared Hospital Services, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy solutions, will hold its quarterly conference call to discuss second quarter 2016 results on Wednesday, August 10, 2016 at 3 pm Eastern Time/ 12 noon Pacific Time. Second quarter results of 2016 will be released the morning of Wednesday, August 10, 2016.. Date/Time Wednesday, August 10, 2016 at 3 pm ET/ 12 noon PT."/>
American Shared Hospital Services Announces Second Quarter 2016 Results Earnings Conference Call
Innovus Pharmaceuticals, Inc. www.innovuspharma.com announced today it will release its second quarter 2016 financial results before the open of trading on Tuesday, August 9, 2016 ahead of its 10- Q to be filed on August 15, 2016. The company will host a conference call at 4:15 p.m. EDT/1: 15 p.m. PDT on the same day to discuss the financial results and recent business developments. To participate in the call, please dial 1-877-883-0383 for domestic callers..."/>
Innovus Pharmaceuticals to Host Its Second Quarter 2016 Financial Report Conference Call on August 9, 2016 at 4:15 p.m. EDT
Seres Therapeutics, Inc. concerning possible violations of federal securities laws. If you purchased shares of Seres and want more information, please contact Joon M. Khang, Esquire, of Khang& Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: 419-3834, or by e-mail at joon@khanglaw.com. There has been no class certification in this case."/>
SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
TBG Diagnostics Limited announces that it will file a certification under Form 15- F with the U.S. Securities and Exchange Commission today in order to voluntarily terminate the registration of its securities and its reporting obligations under Section 13 and Section 15 of the U.S. Securities Exchange Act of 1934, as amended."/>
TBG Diagnostics Limited to File Form 15-F to Voluntarily Terminate SEC Registration
PharmAthene, Inc., a biodefense company developing medical countermeasures against anthrax, today filed a formal protest against the Department of Health and Human Services, challenging its solicitation for a next-generation Anthrax vaccine provider. According to the protest, filed with the U.S. Government Accountability Office, the government's "Request for Proposals" was written in a way that eliminates competition and assures a sole..."/>
PharmAthene Files Protest Against HHS Over Anthrax Vaccine Bidding Process
Keryx Biopharmaceuticals Inc.. Investors who purchased or otherwise acquired shares between February 25, 2016 and August 1, 2016 are encouraged to contact the Firm prior to the October 3, 2016 lead plaintiff motion deadline. If you are a Keryx shareholder who suffered at least $100,000.00 in losses during the Class Period, click here to participate."/>
INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
UnitedHealth Group, are taking immediate action to help people in Howard County, Md., who may be affected by the recent flooding. This includes assisting health plan participants who may..."/>
UnitedHealthcare and Optum Support People Affected by Floods in Howard County, Md.
TransEnterix plans to focus on getting its ALF-X robot approved in the United States before the company shifts attention back to seeking regulatory approval for its SurgiBot robot. TransEnterix executives provided the update in a Friday morning conference call with Wall Street analysts when discussing the company's second-quarter earnings. TransEnterix is seeking to break into a global surgical robotics market that has been..."/>
TransEnterix focuses on winning FDA approval for ALF-X robot [The News & Observer (Raleigh, N.C.)]
Tokai Pharmaceuticals, Inc. concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline.. To participate in this class action lawsuit, click here."/>
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Spine Injury Solutions Schedules Interactive Conference Call to Present 2 nd Quarter 2016 Financial Results and Provide Business Development Update. HOUSTON, August 5, 2016-- Spine Injury Solutions, Inc., a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar spine injury sector, today announced that it has scheduled an interactive video Investor conference call for August 11, at 4:20 p.m. to discuss the..."/>
Spine Injury Solutions Schedules Interactive Conference Call
Chemed Corporation announced today that the Board of Directors has declared a quarterly cash dividend of 26- cents per share on the Company’ s capital stock, payable on September 2, 2016, to shareholders of record as of August 15, 2016. This is a 2- cent, or 8.3%, increase over the 24- cent dividend paid in June 2016. The previous dividend increase was in August 2015, when the Board raised the dividend from 22- cents to 24- cents per share."/>
Chemed Corporation Increases Quarterly Dividend 8.3%
ProPhase Labs announced today that financial results for the second quarter, ended June 30, 2016, will be released after the market closes on Tuesday, August 9, 2016. A conference call will be held on Wednesday August 10 th, at 10:00 am EDT. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and second quarter results. There will be a question and answer session following..."/>
ProPhase Labs to Release Second Quarter 2016 Results on Tuesday, August 9th
American Renal Associates Holdings, Inc.. Lifshitz& Miller announces investigation into possible breaches of fiduciary duties by the board of ARA."/>
Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo Loco Holdings, Inc., EndoChoice Holdings, Inc., Full Circle Capital Corporation and ZIOPHARM Oncology, Inc.
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has filed an international patent application with the US Patent& Trademark Office that covers transdermal extended-release formulations of doxylamine succinate and pyridoxine hydrochloride in combination, relating to the Company's AQS1303 program to treat pregnant women experiencing nausea and..."/>
Aequus Announces Advancement of Anti-Nausea Transdermal Extended-Release Patent Application
GSK unveils campaign to help prevent meningitis
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 18 th Annual Pacific Crest Global Technology Leadership Forum in Vail, Colorado. Lidia Fonseca, the company's Senior Vice President and CIO, will discuss the company's technology solutions and the role of technology within the organization. The presentation is scheduled for Tuesday, August 9th,..."/>
Quest Diagnostics To Speak At The 18th Annual Pacific Crest Global Technology Leadership Forum
Trevena, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing biased ligands to deliver the next generation of GPCR targeted medicines. Trevena's oliceridine is in Phase 3 development for the management of moderate to severe acute pain, and is the first pain program granted Breakthrough Therapy designation by the U.S. View source version on businesswire.com: http://www.businesswire.com/news/home/20160805005022/en/."/>
Company Profile for Trevena, Inc.
Premier Inc., a health care improvement company. Only 38 hospitals received a citation of merit for achieving top performance in any four of the six areas measured in the collaborative-- cost and efficiency, inpatient and outpatient evidence-based care, mortality, safety, patient experience and..."/>
BRIEF: American News, Aberdeen, S.D., column [American News, Aberdeen, S.D.]

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary640 Articles
Information Technology585 Articles
Financials479 Articles
Health Care336 Articles
Industrials319 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.